NYSE · LLY
Eli Lilly and Company (LLY)
$1,251.61+$42.87 (+3.55%)
Close on Thursday, 15 October 2026 · previous close $1,208.74
Pre-market $1,255.00 +0.27% at 8:07 AM ET
Quarterly revenue
$23.0B
+47.7% vs. a year earlier · Quarter ended 30 Jun 2026
YTD +16.5%1M +10.0%Mkt cap $1.2T52-wk range $799.57–$1,280.34
What happened
- Eli Lilly closed at $1,251.61 on Thursday, 15 October, up 3.55%. It is up 16.5% this year, 2.2% below its 52-week closing high.
- In pre-market trading it was at $1,255.00 (+0.27%) at 8:07 AM ET.
- Its latest reported quarter (quarter ended 30 Jun 2026) showed revenue of $23.0B, up 47% from $15.6B, and net income of $7.1B.
- Its most recent 8-K, filed 5 Aug 2026, reported results of operations.
- Next earnings: Thursday, 29 October; consensus EPS $6.40.
LLY price chart
$1,150$1,200$1,250AugSepOct$1252
$1,000$1,200MayJunJulAugSepOct$1252
$800$1,000$1,200NovDecJan '26FebMarAprMayJunJulAugSepOct$1252
Key numbers
| Revenue (latest quarter) | $23.0B+47.7% year over year · Quarter ended 30 Jun 2026 |
|---|---|
| Revenue (last 4 quarters) | $79.7B |
| Net income | $7.1Bup 25% from $5.7B a year earlier |
| Diluted EPS | $7.94vs. $6.29 a year earlier |
| Cash & equivalents | $8.9Bat 30 Jun 2026 |
| Market cap | $1.18TNasdaq |
| 52-week closing range | $799.57 – $1,280.34high on 19 Aug 2026 |
| Latest periodic report | 10-Qfiled 5 Aug 2026 · period 30 Jun 2026 |
| Next earnings | 29 Oct 2026Nasdaq earnings calendar |
| Industry | Biotechnology: Pharmaceutical PreparationsHealth Care |
Revenue by quarter
In the filing
Eli Lilly's latest 10-Q, filed 5 August 2026 for the period ended 30 June 2026, reported revenue of $23.0B, up 47% from $15.6B a year earlier, and 16.0% more than the previous quarter.
Net income was $7.1B (up from $5.7B). Diluted EPS was $7.94, against $6.29 a year before. Cash and equivalents stood at $8.9B on 30 Jun 2026.
Latest 8-K · 5 Aug 2026
Eli Lilly reported results of operations. Read on SEC.gov
Earnings vs. expectations
Reported EPS Consensus
Recent SEC filings
| Date | Form | What it is |
|---|---|---|
| 5 Aug 2026 | 10-Q | Quarterly report |
| 5 Aug 2026 | 8-K | Current report: reported results of operations |
| 20 May 2026 | 8-K | Current report: disclosed another material event |
| 8 May 2026 | 424B2 | Prospectus supplement |
| 7 May 2026 | 8-K | Current report: reported shareholder vote results |
| 6 May 2026 | 424B2 | Prospectus supplement |
| 30 Apr 2026 | 10-Q | Quarterly report |
| 30 Apr 2026 | 8-K | Current report: reported results of operations |
The daily filings brief
Before the US open: the movers, the SEC filings and the earnings that matter. Free, one short email per US trading day.
We only use your email to send the brief.